Life Science Analytics - Global Strategic Business Report 2026: Capitalize on a US$6.6 Billion Revenue Surge to 2032 as IBM, Oracle, Accenture, SAS, and Cognizant Disrupt Data-Driven Healthcare

La traducción aún no está lista. Se muestra el artículo original.

Company Logo Boost ROI with AI, machine learning and cloud analytics to accelerate drug development, personalize care, optimize trials and uncover new revenue opportunities. Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Life Science Analytics - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global life science analytics market was valued at US$11 billion in 2025 and is projected to reach US$17.6 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period.